Who is sponsoring NCT03047941?

NCT03047941 is sponsored by Astes.

What drugs are being tested in NCT03047941?

Interventions in NCT03047941: Determination of optimal cutoff values..

What condition does NCT03047941 study?

NCT03047941 studies Sleep Apnea, Obstructive.

Is NCT03047941 still recruiting?

NCT03047941 is currently withdrawn. Last updated 13 January 2020.

Last reviewed 2020-01-13 · How we verify

NCT03047941

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determination of Optimal Cutoff Value for Screening Severe Hypoxemic OSA (Obstructive Sleep Apnea) Patients

Withdrawn Last updated 13 January 2020

What this trial tests

trial testing Determination of optimal cutoff values. in Sleep Apnea, Obstructive. Withdrawn.

Timeline

13 February 2017

Primary endpoint
30 September 2022

31 October 2022

Quick facts

Lead sponsor	Astes
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	13 February 2017
Primary completion	30 September 2022
Estimated completion	31 October 2022
Sites	1 location across Belgium

Drugs / interventions tested

Determination of optimal cutoff values.

Conditions studied

Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →

Sponsor

Astes — full company profile →

Who can join

18 and older, any sex, with Sleep Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The 4 following scores have been proposed to detect OSA (Obstructive Sleep Apnea): DES-OSA, STOP-Bang, P-SAP, and OSA50. The aim of this study is to evaluate the optimal cutoff value of these four scores to detect specifically serve OSA patients with hypoxemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Apnea, Obstructive

Currently open trials in the same condition.

NCT06828835 — The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention · NA · recruiting
NCT06915831 — Type 1 Diabetes and Obstructive Sleep Apnea · NA · recruiting
NCT07176767 — The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents · recruiting
NCT06573372 — Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea · recruiting
NCT06848647 — Treatment of Sleep Apnea to Improve Metabolic Health · recruiting

Other Astes trials

Trials by the same sponsor.

NCT05711329 — Comparison of Methodology Proposed by the SFAR for the Detection by Videoconference of Obstructive Sleep Apnea. · not yet recruiting
NCT05709964 — Comparison of Demographic Data Mentioned by the Patients or Measured by a Physician · completed
NCT03983564 — Derivation and Validation of a Combination of BOSTON Score and DES-OSA Score for Selection of OSA Patients. · completed
NCT05345665 — Comparison of Three Methods of Anesthesia to Achieve a Nerve Block Anesthesia. · NA · completed
NCT03752437 — Comparison of Two Dosages of Heparin Before Extracorporeal Circulation · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03047941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Astes
Last refreshed: 13 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03047941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing